International Flavors & Fragrances R&D decreased by 4.6% to $166.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from $164.00M to $166.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 2.5% CAGR.
Analysis
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_developmentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $164.00M | $156.00M | $166.00M | $157.00M | $158.00M | $145.00M | $143.00M | $161.00M | $161.00M | $157.00M | $157.00M | $166.00M | $173.00M | $162.00M | $170.00M | $164.00M | $182.00M | $174.00M | $174.00M | $166.00M |
| QoQ Change | — | -4.9% | +6.4% | -5.4% | +0.6% | -8.2% | -1.4% | +12.6% | +0.0% | -2.5% | +0.0% | +5.7% | +4.2% | -6.4% | +4.9% | -3.5% | +11.0% | -4.4% | +0.0% | -4.6% |
| YoY Change | — | — | — | — | -3.7% | -7.1% | -13.9% | +2.5% | +1.9% | +8.3% | +9.8% | +3.1% | +7.5% | +3.2% | +8.3% | -1.2% | +5.2% | +7.4% | +2.4% | +1.2% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Scent | $55.00M | $57.00M | $58.00M | $55.00M | $62.00M | $63.00M | $61.00M | $54.00M |
| Taste | — | — | — | $40.00M | $47.00M | $41.00M | $44.00M | $43.00M |
| Food Ingredients | — | — | — | $12.00M | $14.00M | $13.00M | $15.00M | $14.00M |
| Health & Biosciences | $50.00M | $44.00M | — | $52.00M | $55.00M | $57.00M | — | — |
| Nourish | $55.00M | $55.00M | $55.00M | — | — | — | — | — |
| Pharma Solutions | $7.00M | $6.00M | $6.00M | $5.00M | $3.00M | — | — | — |
| Total | $173.00M | $162.00M | $170.00M | $164.00M | $182.00M | $174.00M | $174.00M | $166.00M |
Nourish is derived from annual filings.
Nourish, Pharma Solutions were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
R&D at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's r&d?
- International Flavors & Fragrances (IFF) reported r&d of $166.00M in Q1 2026.
- How has International Flavors & Fragrances's r&d changed year-over-year?
- International Flavors & Fragrances's r&d increased by 1.2% year-over-year, from $164.00M to $166.00M.
- What is the long-term trend for International Flavors & Fragrances's r&d?
- Over 4 years (2021 to 2025), International Flavors & Fragrances's r&d has grown at a 2.5% compound annual growth rate (CAGR), from $629.00M to $694.00M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.